Inhibition of Snai2 is considered a promising approach to prevent cancer metastasis and resistance to therapy, and there is considerable evidence showing that Snai2-targeting reduces the capability of breast cancer cells to migrate and disseminate to distal organs by reducing their stem-like properties and EMT features [22]. Here, SNAI2 is linked to breast cancer.